Radcliffe Capital Management, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 77 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$4,613,271
+1.8%
456,7640.0%0.15%
+33.9%
Q3 2022$4,533,000
+12.8%
456,764
+12.5%
0.11%
+18.5%
Q2 2022$4,018,000
+0.4%
405,9000.0%0.09%
+1.1%
Q1 2022$4,002,000
+0.2%
405,9000.0%0.09%
-13.3%
Q4 2021$3,994,000
+1.0%
405,9000.0%0.10%
-8.7%
Q3 2021$3,953,000
+0.7%
405,9000.0%0.12%
-6.5%
Q2 2021$3,925,000405,9000.12%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q4 2021
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$8,069,9103.84%
Corbin Capital Partners, L.P. 928,124$9,373,9602.85%
Arena Capital Advisors, LLC- CA 300,000$3,029,9701.65%
RPO LLC 359,009$3,625,9551.24%
Alpha Wave Global, LP 532,570$5,378,9570.98%
MMCAP International Inc. SPC 599,321$6,053,0820.61%
GLAZER CAPITAL, LLC 2,283,910$23,0670.60%
GRITSTONE ASSET MANAGEMENT LLC 39,247$396,3910.50%
CVI Holdings, LLC 292,563$2,954,8860.38%
FIR TREE CAPITAL MANAGEMENT LP 635,837$6,421,9540.33%
View complete list of BIOTECH ACQUISITION COMPANY shareholders